Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Forte Biosciences Inc
(NQ:
FBRX
)
0.6010
-0.0290 (-4.60%)
Streaming Delayed Price
Updated: 3:58 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Forte Biosciences Inc
< Previous
1
2
3
4
Next >
61 Biggest Movers From Yesterday
July 23, 2021
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
July 22, 2021
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares climbed 129.7% to $12.75 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating...
Via
Benzinga
Earnings Scheduled For May 10, 2021
May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...
Via
Benzinga
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
July 12, 2021
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
July 01, 2021
From
Forte Biosciences, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 14, 2021
May 14, 2021
Upgrades Canaccord Genuity upgraded the previous rating for Mogo Inc (NASDAQ:MOGO) from Hold to Speculative Buy. For the first quarter, Mogo had an EPS of $0.06, compared...
Via
Benzinga
Forte Biosciences, Inc. Announces First Quarter 2021 Results and Provides a General Business Update
May 10, 2021
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences, Inc. to Announce First Quarter 2021 Results and Provide a General Business Update
May 03, 2021
From
Forte Biosciences, Inc.
Via
Business Wire
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.